Future Oncology, Vol. 4, No. 2. (April 2008), pp. 271-287.
Drug Discovery Today: Technologies, Vol. 2, No. 4. ( 2005), pp. 345-351.
Nature reviews. Cancer, Vol. 3, No. 4. (April 2003), pp. 267-275.
Nat Med (14 October 2007)
by Sandip
Ray, Markus
Britschgi, Charles
Herbert, Yoshiko
Takeda-Uchimura, Adam
Boxer, Kaj
Blennow, Leah F F
Friedman, Douglas R R
Galasko, Marek
Jutel, Anna
Karydas, Jeffrey A A
Kaye, Jerzy
Leszek, Bruce L L
Miller, Lennart
Minthon, Joseph F F
Quinn, Gil D D
Rabinovici, William H H
Robinson, Marwan N N
Sabbagh, Yuen T T
So, D Larry L
Sparks, Massimo
Tabaton, Jared
Tinklenberg, Jerome A A
Yesavage, Robert
Tibshirani, Tony
Wyss-Coray
J Vet Intern Med, Vol. 21, No. 3. (n 2007), pp. 451-457.
European Journal of Cancer and Clinical Oncology, Vol. 25, No. 1. (January 1989), pp. 123-128.
Cancer Res, Vol. 62, No. 22. (15 November 2002), pp. 6750-6755.
The Journal of cardiovascular nursing, Vol. 23, No. 2. (l 2008), pp. 153-158.
Arch Intern Med, Vol. 167, No. 17. (24 September 2007), pp. 1837-1844.
NeuroRX, Vol. 1, No. 2. (April 2004), pp. 284-294.
Chemosphere, Vol. 51, No. 1. (April 2003), pp. 13-23.
Science, Vol. 319, No. 5860. (11 January 2008), pp. 189-192.
IARC Sci Publ, No. 157. (2004), pp. 437-450.
Ther Drug Monit, Vol. 28, No. 1. (February 2006), pp. 35-38.
Clin Chem, Vol. 50, No. 5. (May 2004), pp. 793-795.
Mol Cell Proteomics (19 February 2006)
Cad Saude Publica, Vol. 17, No. 3. (n 2001), pp. 467-480.
Toxicol Pathol, Vol. 32 Suppl 1 (r 2004), pp. 116-121.
J Proteome Res, Vol. 5, No. 3. (March 2006), pp. 461-462.
Mol Cell Proteomics (17 March 2006)
Clin Cancer Res, Vol. 7, No. 5. (May 2001), pp. 1118-1126.
AAPS J, Vol. 8, No. 1. (2006)
Curr Drug Metab, Vol. 7, No. 5. (June 2006), pp. 525-539.
Clin Chem, Vol. 49, No. 1. (January 2003), pp. 23-31.
J Nutr, Vol. 132, No. 8 Suppl. (August 2002)
Pharm Res, Vol. 23, No. 2. (February 2006), pp. 312-328.
by JW
Lee, V
Devanarayan, YC
Barrett, R
Weiner, J
Allinson, S
Fountain, S
Keller, I
Weinryb, M
Green, L
Duan, JA
Rogers, R
Millham, PJ
O'Brien, J
Sailstad, M
Khan, C
Ray, JA
Wagner
Arq Bras Endocrinol Metabol, Vol. 49, No. 5. (October 2005), pp. 613-614.
Expert Review of Molecular Diagnostics, Vol. 6, No. 2. (March 2006), pp. 179-191.
Br J Radiol, Vol. 76 Spec No 1 (2003)
Folia Neuropathol, Vol. 43, No. 3. (2005), pp. 193-196.
Toxicol Pathol, Vol. 32 Suppl 1 (r 2004), pp. 1-2.
Eur Respir J, Vol. 19, No. 6. (June 2002), pp. 1151-1158.
Clin Chem, Vol. 48, No. 8. (August 2002), pp. 1147-1150.
J Nutr, Vol. 134, No. 6 Suppl. (June 2004)
Proteomics, Vol. 6, No. 10. (May 2006), pp. 2947-2958.
J Clin Pharmacol, Vol. 43, No. 4. (April 2003), pp. 329-341.
Clin Cancer Res, Vol. 10, No. 11. (1 June 2004), pp. 3881-3884.
by GJ
Kelloff, RC
Bast, DS
Coffey, AV
D'Amico, RS
Kerbel, JW
Park, RW
Ruddon, GJ
Rustin, RL
Schilsky, CC
Sigman, GF
Woude
NeuroRx, Vol. 2, No. 4. (October 2005), pp. 683-695.
Expert Rev Proteomics, Vol. 3, No. 1. (February 2006), pp. 45-62.
Mol Cell Proteomics, Vol. 3, No. 4. (April 2004), pp. 345-354.
Clin Chem, Vol. 48, No. 8. (August 2002), pp. 1198-1205.
NeuroRx, Vol. 1, No. 2. (April 2004), pp. 182-188.
J Natl Cancer Inst, Vol. 92, No. 10. (17 May 2000)
J Am Osteopath Assoc, Vol. 105, No. 9. (September 2005), pp. 409-416.
Endocr Relat Cancer, Vol. 11, No. 3. (September 2004), pp. 477-488.
Toxicol Pathol, Vol. 32 Suppl 1 (r 2004), pp. 99-105.
NeuroRx, Vol. 1, No. 2. (April 2004), pp. 189-195.
J Endocrinol, Vol. 186, No. 1. (July 2005), pp. 1-20.
The Holocene, Vol. 9, No. 2. (March 1999), pp. 223-229.